Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-076900

Options or other derivatives

  • Director acquired 816,067 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Alleva Lawrence M Director 2022-07-01 Grant or award · Option to purchase Ordinary Shares +816,067 816,067 D
Loading xslF345X03/tm2220260-6_4seq1.xml…